Healthcare Global Enterprises LtdNSE: HCG
Open the Healthcare Global Enterprises Ltd page
Follow Healthcare Global Enterprises LtdFree account. Get a note when Healthcare Global Enterprises Ltd files.
Q1 FY27 results analysis · August 07, 2026

Healthcare Global Enterprises Ltd (HCG) Q1 FY27 Results Analysis: Revenue Growth Misses 15% Target, EBITDA Margin Expansion Minimal

+189.9%PAT year on year, Rs. 13.77 Cr
Cofacto ResearchPublished August 07, 20262 min readNegative read
Quick summary

Healthcare Global Enterprises Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 693.39 Cr (+13.34% YoY) and PAT growth of +189.89% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 06, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 693.39 Cr (+13.34% YoY)
PAT (Q1)Rs. 13.77 Cr (+189.89% YoY)
EBITDA margin17.77% (+4 bps YoY)
EPS (Q1)Rs. 0.92 (+170.59% YoY)
Market capRs. 10,130.15 Cr
CMPRs. 678.50

Quarter Snapshot

Consolidated revenue growth of 13.34% missed the 15%+ guidance, while standalone growth met the target. EBITDA margin expansion was minimal, raising concerns about achieving the annual 100 bps target. Strong PAT growth was partly driven by one-time gains and lower finance costs.

Key Investment Insights

Key Positives

  • Standalone revenue grew 15.13% YoY, meeting the 15%+ guidance
  • PAT-owners grew 189.89% YoY to Rs.13.77 Cr
  • Finance costs declined 12.32% YoY, reflecting deleveraging
  • Normalized PAT-owners (excluding one-time gain) grew 148.8% YoY
  • Subsidiary contribution to PAT-owners increased to 59.5% from 27.4% YoY

Risk Factors

  • Consolidated revenue growth of 13.34% YoY missed the 15%+ guidance
  • EBITDA margin expanded only 4 bps YoY, below the 100 bps annual target
  • Medical consultancy charges grew 18.38% YoY, outpacing revenue by ~500 bps
  • Other expenses grew 17.16% YoY, also outpacing revenue

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.